Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,431 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,448 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06146985 | Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid Cancer | unknown | Phase 2 | 67 | Ruijin HospitalOTHER | 0 | Nov 28, 2023 | clinicaltrials |
| NCT05576272 | A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma | unknown | Phase 2 / Phase 3 | 460 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06107114 | Cetuximab+Zimberelimab in Combination With Cisplatin and Nab-paclitaxel in Resctable Head and Neck Squamous Cell Carcinoma(CZCNRHNSCC) | unknown | Phase 2 | 52 | Xuekui LiuOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06142318 | Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma | unknown | Phase 2 | 66 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT05989555 | Effects of Radioactive Iodine on the Immune System in Thyroid Cancer(SCIMITAR) | unknown | — | 30 | Radboud University Medical CenterOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06103617 | Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer | unknown | Phase 2 | 10 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06136962 | Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life | unknown | — | 500 | Fujian Cancer HospitalOTHER_GOV | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06138483 | A New Mutational and Epigenetic Signature to Predict Early OPSCC Relapse | unknown | — | 267 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT02624128 | Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck(V-CHANCE) | unknown | Phase 2 | 39 | National Cancer Institute, NaplesOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06121102 | Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharyngeal Cancer Pain | unknown | N/A | 60 | National Cancer Institute, EgyptOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06129201 | Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging | unknown | — | 5,000 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT02229656 | Olaparib and Radiotherapy in Head and Neck Cancer | unknown | Phase 1 | 12 | The Netherlands Cancer InstituteOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT05094804 | A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents | unknown | Phase 1 / Phase 2 | 172 | OncoResponse, Inc.INDUSTRY | 1 | Nov 2, 2023 | clinicaltrials |
| NCT05182931 | A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)(I-FIRST) | unknown | Phase 2 | 80 | Olivia Newton-John Cancer Research InstituteOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT03918382 | Patient-Reported Outcomes in Head and Neck Cancer(DAHANCA PRO) | unknown | N/A | 291 | Rigshospitalet, DenmarkOTHER | 1 | Oct 27, 2023 | clinicaltrials |
| NCT06011291 | A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer | unknown | Phase 1 | 73 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Oct 27, 2023 | clinicaltrials |
| NCT06102447 | Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell Carcinoma | unknown | N/A | 36 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT05817617 | Vitamin D and Head and Neck Cancer: Impact on Toxicity and Prognosis | unknown | — | 953 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Oct 25, 2023 | clinicaltrials |
| NCT06100081 | Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck(REFLECT) | unknown | N/A | 35 | University Medical Center GroningenOTHER | 1 | Oct 25, 2023 | clinicaltrials |
| NCT04277858 | Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.(NECTORS) | unknown | Phase 2 | 60 | Nader SadeghiOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT05545852 | A Clinical Study of Transaxillary Endoscopic and Open Thyroidectomy for PTC | unknown | N/A | 290 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Oct 18, 2023 | clinicaltrials |
| NCT05202626 | Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images | unknown | — | 100 | Chinese Academy of SciencesOTHER_GOV | 1 | Oct 17, 2023 | clinicaltrials |
| NCT05259319 | Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)(IMMUNOs-SBRT) | unknown | Phase 1 | 92 | Centre Georges Francois LeclercOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT06086119 | Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers | unknown | — | 31 | Regina Elena Cancer InstituteOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT06081582 | Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC | unknown | Phase 2 | 33 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT05217212 | Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer? | unknown | — | 100 | Luzerner KantonsspitalOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT05626829 | Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma | unknown | Phase 2 | 18 | Jian GuanOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT05097625 | Head and Neck Early Relapse Detection Study (HERD)(HERD) | unknown | — | 200 | University College, LondonOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT05909020 | EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem | unknown | — | 165 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 3, 2023 | clinicaltrials |
| NCT06060288 | Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening | unknown | — | 174 | Cairo UniversityOTHER | 0 | Oct 3, 2023 | clinicaltrials |
| NCT06051747 | Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea) | unknown | Phase 1 / Phase 2 | 1 | Ja Seong Bae, MD, phDOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT01586767 | Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy | unknown | N/A | 45 | Massachusetts General HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05520814 | PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial | unknown | Phase 2 | 50 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06035653 | A Human Versus Machine Comparison Study(HuVeM) | unknown | — | 40 | East and North Hertfordshire NHS TrustOTHER_GOV | 1 | Sep 18, 2023 | clinicaltrials |
| NCT06041464 | Study of HLA-DR in Cell Cultures Isolated From Primary Squamous Cell Carcinoma | unknown | — | 4 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Sep 18, 2023 | clinicaltrials |
| NCT05393297 | InGReS: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study(InGReS) | unknown | N/A | 15 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06024980 | Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy(SPPDPL) | unknown | N/A | 50 | Guangdong Provincial People's HospitalOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT04593186 | Magnifying NBI for Occult NPC | unknown | N/A | 246 | Chinese University of Hong KongOTHER | 1 | Sep 7, 2023 | clinicaltrials |
| NCT04872517 | Meridian Energy Changes of Head and Neck Cancer Patients After Chemotherapy or Radiotherapy | unknown | N/A | 34 | Liao Jian AnOTHER | 1 | Sep 7, 2023 | clinicaltrials |
| NCT05949749 | A Retrospective Study Reveals the Relationship Between gp42-IgG Epitopes and EBV-associated NPC | unknown | — | 1,000 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT06023875 | Neoadjuvant Cadonilimab in Combination With Cisplatin and Nab-paclitaxel in Resectable Head and Neck Squamous Cell Carcinoma(NCCCNRHNSCC) | unknown | Phase 2 | 30 | Xuekui LiuOTHER | 1 | Sep 5, 2023 | clinicaltrials |
| NCT05451576 | Sodium Selenite Supplementation in Patients With Head and Neck Cancer | unknown | N/A | 60 | Chang Gung Memorial HospitalOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT04009161 | Osteoradionecrosis Rate in Patients Undergoing Radiotherapy for Head and Neck Cancer Treatment. | unknown | — | 160 | Catholic University of the Sacred HeartOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06016699 | Immunological Function After Radiation With Either Proton or Photon Therapy(PRO-IMMUNO) | unknown | — | 40 | University Medical Center GroningenOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06016400 | Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma | unknown | Phase 2 / Phase 3 | 412 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT05859828 | The GOAL27-6 Study | unknown | — | 60 | East and North Hertfordshire NHS TrustOTHER_GOV | 1 | Aug 25, 2023 | clinicaltrials |
| NCT06011993 | Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma （neoHNSCC） | unknown | — | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 25, 2023 | clinicaltrials |
| NCT05102292 | The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation | unknown | Phase 1 / Phase 2 | 25 | Shanghai Henlius BiotechINDUSTRY | 1 | Aug 21, 2023 | clinicaltrials |
| NCT05610293 | T1 Squamous Cell Carcinomas of the Lip | unknown | — | 300 | Maastricht University Medical CenterOTHER | 1 | Aug 16, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Nov 28, 2023source: clinicaltrials